PGE2 and Poloxamer Synperonic F108 Enhance Transduction of Human HSPCs with a ß-Globin Lentiviral Vector.

Masiuk, Katelyn E; Zhang, Ruixue; Osborne, Kyle; Hollis, Roger P; Campo-Fernandez, Beatriz; Kohn, Donald B

Masiuk, Katelyn E; Zhang, Ruixue; Osborne, Kyle; Hollis, Roger P; Campo-Fernandez, Beatriz; Kohn, Donald B.

Afiliación

Masiuk KE; Department of Microbiology, Immunology & Molecular Genetics, University of California, Los Angeles, Los Angeles, CA 90095, USA.
Zhang R; Department of Microbiology, Immunology & Molecular Genetics, University of California, Los Angeles, Los Angeles, CA 90095, USA.
Osborne K; Department of Microbiology, Immunology & Molecular Genetics, University of California, Los Angeles, Los Angeles, CA 90095, USA.
Hollis RP; Department of Microbiology, Immunology & Molecular Genetics, University of California, Los Angeles, Los Angeles, CA 90095, USA.
Campo-Fernandez B; Department of Microbiology, Immunology & Molecular Genetics, University of California, Los Angeles, Los Angeles, CA 90095, USA.
Kohn DB; Department of Microbiology, Immunology & Molecular Genetics, University of California, Los Angeles, Los Angeles, CA 90095, USA.

Mol Ther Methods Clin Dev ; 13: 390-398, 2019 Jun 14.

Article en En | MEDLINE | ID: mdl-31024981

Palabras clave

HSCs; gene therapy; lentivirus; sickle cell disease

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Idioma: En Revista: Mol Ther Methods Clin Dev Año: 2019 Tipo del documento: Article País de afiliación: Estados Unidos Pais de publicación: Estados Unidos

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google